6-Aryl- and 6,7-diaryl-1,3-dimethyl-1-perimidin-2(3)-ones: synthesis, conformational stability, crystal structure and optical properties.

6-Bromo- and 6,7-dibromo-1,3-dimethyl-1-perimidin-2(3)-ones were arylated with arylboronic acids under Suzuki-Miyaura reaction conditions to afford 6-aryl-, 6-bromo-7-aryl- and 6,7-diaryl-1,3-dimethyl-1-perimidin-2(3)-ones. A comparison of the X-ray structural parameters of -diaryl derivatives of 1,3-dimethyl-1-perimidin-2(3)-one, naphthalene and 1,8-bis(dimethylamino)naphthalene (proton sponge) was performed. Based on the data of dynamic H NMR spectroscopy and quantum-chemical calculations, barriers to /-isomerization of 6,7-diaryl-1,3-dimethyl-1-perimidin-2(3)-ones were estimated.

Pivotal role of Tc NMR spectroscopy in solid-state and molecular chemistry.

The radioelement Technetium (element 43) pertains to various domains including the nuclear enterprise (i.e., spent nuclear fuel (SNF) reprocessing and nuclear waste remediation) and nuclear medicine (i.

Monomeric and Dimeric Boron (III) Subphthalocyanines Functionalized with 4-Hydroxy-Benzoic Acid as Potential Photosensitizers and Photocatalysts in Sulfoxidation.

Axial modification of boron (III) subphthalocyanine bromides with 4-hydroxy-benzoic acid successfully led to the formation of the macrocycles with anchored 4-carboxyphenoxy group [RsPcPHBA] (R=Bu, H) in the axial position and to a new dimer [sPcPHBAsPc] as minor product. Tri-tert-butyl and unsubstituted subphthalocyanines bearing benzoate ([BusPcBA], [sPcBA]), phenoxy-group ([BusPcOPh], [sPcOPh])) in the axial position, have been also investigated as well as control sPcs. All compounds were characterized by NMR, IR, UV-Vis and mass spectrometry.

[Reduction in the need for glucocorticoids on the background of therapy with biologic disease-modifying antirheumatic drugs and Janus kinase inhibitors in rheumatoid arthritis: evidence from real clinical practice].

Background: Clinical guidelines for the treatment of rheumatoid arthritis (RA) recommend reducing the use of glucocorticoids (GCs) due to the high risk of associated complications.

Aim: To determine the frequency of GC cancellations and dose reductions in real clinical practice, while taking into account active RA therapy.

Materials And Methods: The study group consisted of 303 patients with RA reliable according to ACR/EULAR criteria (women 79.